Supplemental Figures 1-2 from Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870)
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure 1. Tumor infiltrating Treg; Supplemental Figure 2. Treg and IFN�-CD8.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361929109